Results 141 to 150 of about 3,248 (232)

Is low-dose tafenoquine combined with dihydroartemisinin-piperaquine a potential risk factor for Plasmodium vivax resistance to 8-aminoquinolines? [PDF]

, 2022
Temi Lampejo
openalex   +1 more source

ESG Performance Summary [PDF]

Noms variants de l'empresa : GSKAltres títols : Responsible Business Suplement, Corporate and social responsibility report, Corporate responsibility ...
GlaxoSmithKline
core  

Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date

Drug Design, Development and Therapy, 2016
Yehenew A Ebstie,1,* Solomon M Abay,2,* Wondmagegn T Tadesse,3 Dawit A Ejigu4 1Department of Microbiology, Immunology and Parasitology, 2Department of Pharmacology, 3Department of Pharmacology and Clinical Pharmacy, School of Medicine, College of Health
Ebstie YA, Abay SM, Tadesse WT, Ejigu DA
doaj  

Repurposing tafenoquine as a potent antifungal agent against Candida haemulonii sensu stricto [PDF]

Larissa Rodrigues Pimentel, Fabíola Lucini, Gabrieli Argueiro da Silva, Simone Simionatto, Luana Rossato   +4 more
openalex   +1 more source

Unexpected pharmacological and toxicological effects of tafenoquine [PDF]

Occupational Medicine, 2015
openaire   +2 more sources

Decision letter: Comment on 'The clinical pharmacology of tafenoquine in the radical cure of Plasmodium vivax malaria: An individual patient data meta-analysis'

, 2023

openalex   +1 more source

Long-term safety of the tafenoquine antimalarial chemoprophylaxis regimen: A 12-month, randomized, double-blind, placebo-controlled trial

, 2021
Anne Novitt-Moreno, Adam Martidis, Víctor H. González, Janet H. Ransom, Charles Scott, Geoffrey S. Dow, Mark Reid, Bryan Smith, Victor E. Zottig, Lisa Read, Lindsey S. Garver Baldwin, Fred K. Chen   +11 more
openalex   +1 more source

A retrospective analysis of the protective efficacy of tafenoquine and mefloquine as prophylactic anti-malarials in non-immune individuals during deployment to a malaria-endemic area [PDF]

, 2014
Geoffrey S. Dow, William F. McCarthy, Mark Reid, Bryan Smith, Douglas B. Tang, G. Dennis Shanks   +5 more
openalex   +1 more source

Single Low Dose Tafenoquine Combined with Dihydroartemisinin-Piperaquine to Reduce <i>P. Falciparum</i> Transmission: A Phase 2 Single Blind Randomised Clinical Trial in Ouelessebougou, Mali

, 2021
Almahamoudou Mahamar, Merel Smit, William J. Stone, Koualy Sanogo, Youssouf Sinaba, Sidi M. Niambele, Adama Sacko, Sekouba Keita, Oumar M Dicko, Makonon Diallo, Seydina O Maguiraga, Siaka Samaké, Oumar Attaher, Kjerstin Lanke, Rob ter Heine, John Bradley, Matthew B. B. McCall, Djibrilla Issiaka, Skeou F. Traore, Teun Bousema, Chris Drakeley, Alassane Dicko   +21 more
openalex   +1 more source

Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: a cost-effectiveness analysis using a transmission model [PDF]

, 2023
David J. Price, Narimane Nekkab, Wuelton Marcelo Monteiro, Daniel Antunes Maciel Villela, J. A. Simpson, Marcus Lacerda, Michael White, Angela Devine   +7 more
openalex   +1 more source